ETF Trace

Fund report

UCITS · Ireland · Accumulating

RTYS IE00B60SX402

US small-cap stocks
INVESCO RUSSELL 2000 UCITS ETF ETF ON Russell 2000 INVESCO RUSSELL 2000 UCITS ETF
SR200 · SC0K · IRSTF · Invesco

1,971 holdings as of 2026-10-09 · top 10 = 3.3% · TER 0.25% · P/E 19.4

Add to portfolioStart with this fund, then add the others you hold.
Concentration
Well diversifiedtop 10 = 3.3%
diversifiedconcentrated
GROWTH · PRICE DEVELOPMENTrebased to 0%
Holdings
1,971
as of 2026-10-09
Top 10
3.3%
TER
0.25%
cheaper than 47% of peers
Net assets
US$108B
reported in USD
Largest
0.4%
P / E
19.4
covers 65% by weight
Sections
Holdings as of 2026-10-09.
01Overview
the fund's regulatory facts
Distribution
Accumulating
Fund currency
USD
Domicile
Ireland
Structure
Open-ended
First listed
2009-03-31
Volatility 1Y
17.9%
Tracked index
Russell 2000 Total Return Index
How it tracks
Synthetic (swap)
Risk rating
5 of 7
02Valuation and performance
market price return · as of 2026-10-16
1M
-4.6%
3M
-6.9%
6M
-0.5%
YTD
+10.9%
1Y
+10.7%
Trackingfund minus Russell 2000 Total Return Index · annualised
1Y return gap
-0.28 pp/yr
3Y return gap
-0.32 pp/yr
5Y return gap
-0.36 pp/yr
3Y tracking error
0.02%

A positive return gap means the fund finished ahead of the index over that window. The 3Y tracking error shows how variable that monthly gap was; lower means steadier tracking. MethodologyReturn gap and tracking errorReturn gap is the fund's return minus its index over the same months, converted to a yearly rate. Tracking error is the annualised standard deviation of those monthly fund-minus-index returns. Both lines come from the manager's own chart, in the same currency and the exact index variant the fund tracks. We use month-end values so different intraday valuation times are not mistaken for tracking error.. Not investment advice.

Valuation1,754 companies covered · weighted, profitable holdings only
19.4
price / earnings
MethodologyCompany-data coverageThe rest is 34% loss-making companies, which carry no P/E by the positive-earner convention; 1% cannot be reliably linked to the financial and market data used in this analysis. We exclude uncertain matches rather than estimate them.
-0.1%
MethodologyEarnings yieldP/E is price over earnings; earnings yield is the reverse, earnings over price, and reads like a bond yield. P/E covers only the profitable holdings, since a loss-making company has no meaningful P/E. Earnings yield counts the loss-makers too, so it covers more of the fund and can fall below zero when the holdings lose money overall.
covers 98% by weight
2.00
price / book
covers 88% by weight

Computed from company filings and reported position values. MethodologyPortfolio valuationComputed by us from each company's own financial statements and the position values funds report, currency-adjusted and weighted harmonically. P/E covers profitable holdings only. Book value uses the most recent reported quarter.. Not investment advice.

03Holdings
50 largest · as of 2026-10-09
#CompanyIdentifierWeight
1JFROG LTD ILFROG
0.4
2BRIGHTSPRING HEALTH SERVICES, INC. USBTSG
0.4
3TWIST BIOSCIENCE CORP USTWST
0.4
4MOOG INC. USMOG/A
0.3
5UMB Financial Corp USUMBF
0.3
6GLAUKOS CORPORATION USGKOS
0.3
710X GENOMICS INC-CLASS A USTXG
0.3
8Vaxcyte, Inc. USPCVX US
0.3
9Viasat Inc USVSAT
0.3
10SM Energy Co USSM
0.3
11Protagonist Therapeutics Inc USPTGX
0.3
12FIRSTCASH HOLDINGS, INC. USFCFS
0.3
13HUT 8 CORP. USHUT US
0.3
14Caretrust Reit Inc USCTRE
0.3
15Krystal Biotech Inc USKRYS
0.3
16InterDigital Inc USIDCC
0.3
17OLD NATIONAL BANCORP USONB
0.3
18Jackson Financial Inc USJXN
0.3
19Cytokinetics Inc USCYTK
0.3
20MAXLINEAR, INC. USMXL
0.3
21BRINKER INTERNATIONAL, INC. USEAT
0.3
22PBF ENERGY INC. USPBF
0.3
23Ryman Hospitality Properties Inc USRHP
0.3
24TG THERAPEUTICS, INC. USTGTX
0.3
25Oscar Health Inc USOSCR
0.3
26HEALTHEQUITY, INC. USHQY
0.3
27Zeta Global Holdings Corp USZETA
0.3
28SSR Mining Inc USSSRM
0.3
29SILICON LABORATORIES INC. USSLAB
0.2
30ARCOSA, INC. USACA
0.2
31Qualys Inc USQLYS
0.2
32Commercial Metals Co USCMC
0.2
33Plexus Corp USPLXS
0.2
34Fluor Corp USFLR
0.2
35ZURN ELKAY WATER SOLUTIONS CORPORATION USZWS
0.2
36Kymera Therapeutics Inc USKYMR US
0.2
37FEDERAL SIGNAL CORPORATION USFSS
0.2
38TERRENO REALTY CORP USTRNO
0.2
39Matson Inc USMATX
0.2
40COMPASS, INC USCOMP US
0.2
41ESCO TECHNOLOGIES INC. USESE
0.2
42Alkermes PLC IEALKS
0.2
43Enpro Inc. USNPO
0.2
44StoneX Group Inc USSNEX
0.2
45HIMS & HERS HEALTH, INC. USHIMS
0.2
46COMMVAULT SYSTEMS, INC. USCVLT
0.2
47EnerSys USENS
0.2
48Spyre Therapeutics, Inc. USSYRE
0.2
49Lantheus Holdings Inc USLNTH
0.2
50Praxis Precision Medicines Inc USPRAX US
0.2
Add this fund to your portfolio →
04Exposure
Equity 100.0%
By sector
Healthcare19.9%
Financial Services18.8%
Industrials14.0%
Technology13.7%
Consumer Cyclical9.0%
Energy6.7%
Real Estate5.6%
Materials4.2%
Utilities2.8%
Communication Services2.4%
Consumer Defensive2.0%
By country
USUnited States93.7%
BMBermuda1.2%
CACanada1.2%
KYCayman Islands0.7%
CHSwitzerland0.6%
ILIsrael0.5%
IEIreland0.5%
GBUnited Kingdom0.3%
CurrencyUSD 95.8% CAD 1.2% EUR 0.7% CHF 0.6% GBP 0.5%
Issuer's scenario analysisaverage return per year over 5 years
Stress
-24.7%
Unfavourable
+0.8%
Moderate
+7.6%
Favourable
+16.0%
06Where it trades
11 exchanges
ExchangeMICListed since
XetraXETA2009-04-20
Börse StuttgartSTUB2009-05-08
Börse MünchenMUNB2010-12-22
TradegateXGAT2011-03-22
Börse FrankfurtFRAA2011-05-23
London Stock ExchangeXLON2011-09-16
Börse DüsseldorfDUSD2012-02-17
Borsa ItalianaETFP2014-09-05
Börse HamburgHAMN2016-08-01
Börse HannoverHAND2024-12-09
SIX Swiss ExchangeXSWX–

Also admitted to 33 other venues, mostly multilateral trading facilities and regional segments.

See this fund inside your whole portfolio

Paste every fund you hold and see the companies you actually own, merged across all of them, with overlap, concentration and portfolio P/E. You can also test what adding this ETF would change.

Add to portfolio →